XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
 12 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Cash flows from operating activities:      
Net income (loss) $ 8,008 $ (7,868) $ (32,682)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 11,804 13,222 13,006
Amortization of assets subject to financing obligation   2,682 2,682
Amortization of right-of-use assets for operating leases 24,273    
Goodwill and intangible asset impairment expense 0 0 1,164
Bad debt expense 1,767 1,166 1,511
Stock-based compensation 2,077 1,390 1,815
Deferred income taxes 345 0 (2,812)
Equity in earnings of unconsolidated affiliate 0 (399) (385)
Training equipment credits earned, net 541 302 33
Other (gains) losses, net (52) 561 122
Changes in assets and liabilities:      
Receivables (13,749) (1,483) (2,695)
Notes receivable 2,286 1,298 3,393
Prepaid expenses and other current assets (1,016) 3,157 (1,584)
Other assets (76) 1,016 (116)
Accounts payable and accrued expenses 7,020 2,942 3,858
Deferred revenue (2,192) 4,650 (5,663)
Income tax (receivable) payable (6,989) 166 (812)
Accrued tool sets and other current liabilities 1,863 300 1,014
Deferred rent liability 0 (1,677) 5,116
Operating lease liability (25,617)    
Other liabilities 739 321 (318)
Net cash provided by (used in) operating activities 11,032 21,746 (13,353)
Cash flows from investing activities:      
Purchase of property and equipment (9,262) (6,453) (20,606)
Proceeds from disposal of property and equipment 64 34 25
Purchase of held-to-maturity investments (69,678) 0 0
Proceeds received upon maturity of investments 31,289 0 7,739
Proceeds from life insurance policy 1,566 0 0
Purchase of trading securities 0 0 (894)
Proceeds from sales of trading securities 0 0 40,902
Capitalized costs for intangible assets 0 0 (325)
Return of capital contribution from unconsolidated affiliate 261 267 291
Net cash (used in) provided by investing activities (45,760) (6,152) 27,132
Cash flows from financing activities:      
Proceeds from equity offering 49,153 0 0
Payment of preferred stock cash dividend (5,264) (5,250) (5,250)
Payment of financing obligation and finance leases (99) (1,319) (1,107)
Payment of payroll taxes on stock-based compensation through shares withheld (698) (629) (223)
Net cash provided by (used in) financing activities 43,092 (7,198) (6,580)
Change in cash, cash equivalents and restricted cash 8,364 8,396 7,199
Cash and cash equivalents, beginning of period 65,442 58,104 50,138
Restricted cash, beginning of period 15,113 14,055 14,822
Cash, cash equivalents and restricted cash, beginning of period 80,555 72,159 64,960
Cash and cash equivalents, end of period 76,803 65,442 58,104
Restricted cash, end of period 12,116 15,113 14,055
Cash, cash equivalents and restricted cash, end of period 88,919 80,555 72,159
Supplemental disclosure of cash flow information:      
Taxes refunded (113)    
Taxes paid   37 610
Interest paid 7 3,220 3,310
Training equipment obtained in exchange for services 985 772 3,240
Depreciation of training equipment obtained in exchange for services 1,345 1,387 1,386
Change in accrued capital expenditures during the period (490) 316 (1,042)
CARES Act funds received for student emergency grants (See Note 21) 16,565 0 0
CARES Act funds disbursed for student emergency grants (See Note 21) (17,184) 0 0
CARES Act funds received for institutional costs (See Note 21) 13,889 0 0
CARES Act funds for institutional costs included in Receivables, net (See Note 21) $ 1,797 $ 0 $ 0